STD Diagnostics Market By Clinical Indications (Human immunodeficiency virus (HIV), Chlamydia, Trichomoniasis, Syphilis, Genital Herpes, Epididymitis, Gonorrhoea, Genital Warts/Human Papillomavirus (HPV), Vaginitis (Atrophic vaginitis, Vulvodynia), Others); By Technologies (Microscopy, Point-of-care (POC) antigen detection tests, Culture, Nucleic acid amplification tests (NAATs), Others); By Test Types (Swab Tests, Urine Tests, Blood Tests, Combinational Tests); By End User(Hospitals, Clinics, Laboratories, Pathological Centres, Research Institutes, Others); By Product Offerings (Test Kits, Reagents, Assays, Probes, Others); By Region (U.S., Canada, Mexico, Rest of North America, The UK, France, Germany, Italy, Spain, Nordic Countries (Denmark, Finland, Iceland, Sweden, Norway), Benelux Union (Belgium, the Netherlands, Luxembourg), Rest of Europe, China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia), Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa,Brazil, Argentina, Rest of Latin America) – Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2019 - 2027
Report ID :AMI-646 | Category : Healthcare | Published Date : August, 2020 | Pages : 402 | Format :PDF